-
-
-
-
-
-
-
Raymond James Reiterates Outperform Rating on Revvity Inc (RVTY)
-
-
-
-
-
-
-
Revvity partners with Sanofi to develop type 1 diabetes screening test
-
-
-
-
-
-
-
Revvity Inc (RVTY) PT Lowered to $100 at Jefferies
-
-
-
-
-
-
-
Stifel Reiterates Hold Rating on Revvity Inc (RVTY)
-
-
-
-
-
-
-
Revvity Inc (RVTY) PT Raised to $145 at KeyBanc, Citing 'Organic Growth Guidance'
-
-
-
-
-
-
-
Bernstein SocGen Group Downgrades Revvity Inc (RVTY) to Market Perform
-
-
-
-
-
-
-
Revvity (RVTY) Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

